News tagged with national cancer institute

Blincyto approved for rare leukemia

(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.

Dec 03, 2014
popularity not rated yet | comments 0

University of Chicago to establish Genomic Data Commons

The University of Chicago is collaborating with the National Cancer Institute to establish the nation's most comprehensive computational facility that stores and harmonizes cancer genomic data generated through NCI-funded ...

Dec 02, 2014
popularity not rated yet | comments 0

Genetic testing could improve breast cancer prevention

Scientists used mathematical models to show that analysing genetic data, alongside a range of other risk factors, could substantially improve the ability to flag up women at highest risk of developing breast ...

Nov 13, 2014
popularity 5 / 5 (1) | comments 0

Next-gen melanoma drug, TAK-733, excels in lab tests

A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and tr ...

Nov 11, 2014
popularity 4.3 / 5 (4) | comments 0